Sanofi, aiming to speed MS treatment, to acquire Principia Biopharma

Sanofi, aiming to speed MS treatment, to acquire Principia Biopharma

STAT Plus: Sanofi, aiming to speed MS treatment, to acquire Principia Biopharma for $3.68 billion

By MATTHEW HERPER

ERIC PIERMONT/AFP/GETTY IMAGES

The French drug giant is acquiring Principia for $3.68 billion, giving it full control over the multiple sclerosis treatment the companies share.

READ MORE